Indeed, genome-wide association studies [46, 47] suggest that IL-6R signaling is likely to have great effects on the vascular risk and blocking IL-6R may be a therapeutic approach to prevent coronary heart disease. The gene discussed is IL6R; the disease is coronary artery disorder.